Clinical trial
Immunogenicity, Safety and Efficacy of Influenza Vaccine in HIV Infected Children
NCT00883012 is registered in ClinicalTrials.gov with University of Witwatersrand, South Africa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity, Safety and Efficacy of Influenza Vaccine in HIV Infected Children
- Lead sponsor
- University of Witwatersrand, South Africa
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- June 30, 2010
- Enrollment
- 412 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza with pneumonia, influenza virus identified